Picture of Mezzion Pharma Co logo

140410 Mezzion Pharma Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Mezzion Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13,509-36,298-12,728-19,477-34,929
Depreciation
Non-Cash Items-73816,345-1,3536,62420,428
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2,4116,2201,512-6,594-3,075
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-15,071-12,075-11,023-18,489-16,588
Capital Expenditures-6,183-1,761-11,858-13,479-13,273
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-10,15119,171-13,6973,90315,159
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-16,33417,410-25,555-9,5761,886
Financing Cash Flow Items20,000
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities19,112-61647,21467026,731
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-11,6445,18910,847-26,62911,957